Class IIITerminated in FDA datasetApr 15, 2013

Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid, Promotes Circulation and Muscle Development, Dietary Supplement, 50 Vegetarian Capsules, Gluten Free, Serving…

Recalling firm: Nexgen Pharma, Inc.

Why it was recalled

Nexgen Pharma is recalling a certain lot of dietary supplement L-Arginine L-Ornithine Alpha Lipoic Acid Capsules due to subpotency of the Alpha Lipoic Acid ingredient.

Check the codes ↓

The exact product

Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid, Promotes Circulation and Muscle Development, Dietary Supplement, 50 Vegetarian Capsules, Gluten Free, Serving Size 2 Capsules. Each product is produced for a specific customer with their distribution information on the label. A general label template was provided with attachment B information. Product is sold in 50 and 100 ct bottles.

Check the codes

Compare these FDA-provided codes, lot numbers or dates with the product you have.

Match the product, size and code together. A similar name alone does not identify your batch.

Original FDA code information

Lot number 412567.

Recall details

Recall number
F-1338-2013
Event ID
64907
FDA status
Terminated
Initiated
Apr 15, 2013
Reported
May 1, 2013
Classified
Apr 19, 2013
Terminated
Sep 6, 2013
Quantity
4571 bottles.
Location
Colorado Springs, CO, United States
Initiation type
Voluntary: Firm initiated
Notification
Letter

Where it was distributed

Distributed to large and small retailers located nationwide as well as two foreign locations (Canada and Netherlands).

FDA source record · F-1338-2013

Data updated September 16, 2026. View official FDA data ↗

A missing code match is not a guarantee of safety. Follow official FDA and manufacturer guidance.